Dual-contrast photon-counting micro-CT using iodine and a novel bismuth-based contrast agent.

Objectives.To characterize for the first timein vivoa novel bismuth-based nanoparticular contrast agent developed for preclinical applications. Then, to design and testin vivoa multi-contrast protocol for functional cardiac imaging using the new bismuth nanoparticles and a well-established iodine-based contrast agent.Approach.A micro-computed tomography scanner was assembled and equipped with a photon-counting detector. Five mice were administered with the bismuth-based contrast agent and systematically scanned over 5 h to quantify the contrast enhancement in relevant organs of interest. Subsequently, the multi-contrast agent protocol was tested on three mice. Material decomposition was performed on the acquired spectral data to quantify the concentration of bismuth and iodine in multiple structures, e.g. the myocardium and vasculature.Main results.In the vasculature, the bismuth agent provides a peak enhancement of 1100 HU and a half-life of about 260 min. After the injection, it accumulates in the liver, spleen and intestinal wall reaching a CT value of 440 HU about 5 h post injection. Phantom measurements showed that the bismuth provides more contrast enhancement than iodine for a variety of tube voltages. The multi-contrast protocol for cardiac imaging successfully allowed the simultaneous decomposition of the vasculature, the brown adipose tissue and the myocardium.Significance.The new bismuth-based contrast agent was proven to have a long circulation time suitable for preclinical applications and to provide more contrast than iodine agents. The proposed multi-contrast protocol resulted in a new tool for cardiac functional imaging. Furthermore, thanks to the contrast enhancement provided in the intestinal wall, the novel contrast agent may be used to develop further multi contrast agent protocols for abdominal and oncological imaging.

Comparative analysis of nanosystems' effects on human endothelial and monocytic cell functions.

The objective of our work was to investigate the effects of different types of nanoparticles on endothelial (HUVEC) and monocytic cell functions. We prepared and tested 14 different nanosystems comprising liposomes, lipid nanoparticles, polymer, and iron oxide nanoparticles. Some of the tested nanosystems contained targeting, therapeutic, or contrast agent(s). The effect of particles (0-400 µg/mL) on endothelial-monocytic cell interactions in response to TNF-α was investigated using an arterial bifurcation model and dynamic monocyte adhesion assay. Spontaneous HUVEC migration (0-100 µg/mL nanoparticles) and chemotaxis of monocytic cells towards MCP-1 in presence of particles (0-400 µg/mL) were determined using a barrier assay and a modified Boyden chamber assay, respectively. Lipid nanoparticles dose-dependently reduced monocytic cell chemotaxis and adhesion to activated HUVECs. Liposomal nanoparticles had little effect on cell migration, but one formulation induced monocytic cell recruitment by HUVECs under non-uniform shear stress by about 50%. Fucoidan-coated polymer nanoparticles (25-50 µg/mL) inhibited HUVEC migration and monocytic cell chemotaxis, and had a suppressive effect on monocytic cell recruitment under non-uniform shear stress. No significant effects of iron oxide nanoparticles on monocytic cell recruitment were observed except lauric acid and human albumin-coated particles which increased endothelial-monocytic interactions by 60-70%. Some of the iron oxide nanoparticles inhibited HUVEC migration and monocytic cell chemotaxis. These nanoparticle-induced effects are of importance for vascular cell biology and function and must be considered before the potential clinical use of some of the analyzed nanosystems in cardiovascular applications.

In Vivo Quantification of Myocardial Infarction in Mice Using Micro-CT and a Novel Blood Pool Agent.

We herein developed a micro-CT method using the innovative contrast agent ExiTron™ MyoC 8000 to longitudinally monitor cardiac processes in vivo in small animals. Experiments were performed on healthy mice and mice with myocardial infarction inflicted by ligation of the left anterior descending artery. Time-dependent signal enhancement in different tissues of healthy mice was measured and various contrast agent doses were investigated so as to determine the minimum required dose for imaging of the myocardium. Due to its ability to be taken up by healthy myocardium but not by infarct tissue, ExiTron MyoC 8000 enables detection of myocardial infarction even at a very low dose. The signal enhancement in the myocardium of infarcted mice after contrast agent injection was exploited for quantification of infarct size. The values of infarct size obtained from the imaging method were compared with those obtained from histology and showed a significant correlation (R2 = 0.98). Thus, the developed micro-CT method allows for monitoring of a variety of processes such as cardiac remodeling in longitudinal studies.

Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing.

AIM: We report the physicochemical analysis of nanosystems intended for cardiovascular applications and their toxicological characterization in static and dynamic cell culture conditions. METHODS: Size, polydispersity and ζ-potential were determined in 10 nanoparticle systems including liposomes, lipid nanoparticles, polymeric and iron oxide nanoparticles. Nanoparticle effects on primary human endothelial cell viability were monitored using real-time cell analysis and live-cell microscopy in static conditions, and in a flow model of arterial bifurcations. RESULTS & CONCLUSIONS: The majority of tested nanosystems were well tolerated by endothelial cells up to the concentration of 100 µg/ml in static, and up to 400 µg/ml in dynamic conditions. Pilot experiments in a pig model showed that intravenous administration of liposomal nanoparticles did not evoke the hypersensitivity reaction. These findings are of importance for future clinical use of nanosystems intended for intravascular applications.

A pyrrole-containing surfactant as a tecton for nanocomposite SiO2 films.

A surfactant featuring a polymerizable pyrrole head group (dodecyl-dimethyl-(2-pyrrol-1-yl-ethyl)-ammonium bromide, DDPABr) was synthesized. The thermotropic behavior of the surfactant was investigated by differential scanning calorimetry (DSC) and X-ray scattering techniques, with small-angle X-ray scattering (SAXS) analysis revealing a highly ordered lamellar bilayer structure. After full characterization, DDPABr was used in the preparation of mesostructured SiO2 nanocomposite thin films via evaporation-induced self-assembly (EISA). Resulting thin SiO2-DDPABr films were studied by 1D and 2D small-angle X-ray scattering (SAXS) techniques, indicating a lamellar nanocomposite structure. Suitable theoretical SAXS models were applied to fit the experimental 1D SAXS data. The surfactant could be chemically polymerized within the lamellar domains.

Synthesis and phase characterization of a double-tailed pyrrole-containing surfactant: a novel tecton for the production of functional nanostructured materials.

A double-tailed polymerizable (pyrrolylalkyl) ammonium amphiphile has been synthesized, and its interfacial properties and aqueous phase behavior have been studied by polarized optical microscopy and X-ray diffraction. The Krafft temperature is about 27 degrees C, and the critical micelle concentration at 40 degrees C is about 1 mM, as obtained from surface tension measurements, potentiometry, and isothermal titration calorimetry. The lyotropic behavior of the surfactant is found to be of a complex nature. At concentrations higher than the micellar (L1) region, two mesophases have been identified: a second isotropic (L2) phase, which is probably micellar but not fully miscible with water, and a lamellar (L(alpha)) phase, showing interesting alignment properties. Small-angle X-ray scattering analysis of the mesophases has been evaluated in terms of a model of spherical micelles, which describes a mutual arrangement by a structure factor derived from a hard-sphere potential (Percus-Yevick, "PY", approach). Interest in the comprehensive phase behavior of the polymerizable surfactant is based on the desire to integrate the system into a composite material to obtain potentially conducting self-assembled hybrid mesostructures.